These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2006528

  • 21. Specific intravenous carbohydrate therapy. A new concept in inhibiting antibody-mediated rejection--experience with ABO-incompatible cardiac allografting in the baboon.
    Cooper DK, Ye Y, Niekrasz M, Kehoe M, Martin M, Neethling FA, Kosanke S, DeBault LE, Worsley G, Zuhdi N.
    Transplantation; 1993 Oct; 56(4):769-77. PubMed ID: 8212194
    [Abstract] [Full Text] [Related]

  • 22. Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts.
    Makowka L, Chapman FA, Cramer DV, Qian SG, Sun H, Starzl TE.
    Transplantation; 1990 Sep; 50(3):359-65. PubMed ID: 2402783
    [Abstract] [Full Text] [Related]

  • 23. Prolongation of rat cardiac allograft survival by donor pretreatment. Screening of antineoplastic drugs.
    Soots A, Häyry P.
    Transplantation; 1978 May; 25(5):259-64. PubMed ID: 349802
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
    Takahashi M, Shimizu H, Murakami T, Enosawa S, Suzuki C, Takeno Y, Hakamata Y, Kudou S, Izawa S, Yasue T, Kobayashi E.
    Transplant Proc; 2005 May; 37(1):143-5. PubMed ID: 15808575
    [Abstract] [Full Text] [Related]

  • 26. Prolonged cold ischemic times and less donor-recipient histocompatibility accelerate graft vascular disease.
    Czer LS, Wong AV, Soukiasian H, Gallagher S, De Robertis M, Trento A.
    Transplant Proc; 2011 Dec; 43(10):3863-8. PubMed ID: 22172861
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD, Morris RE.
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of combined administration of low dose cyclosporine A with a thromboxane synthetase inhibitor on acute cardiac allograft rejection.
    Sakurai Y, Kagawa K, Kato Y, Otani H, Nonoyama A.
    Transplant Proc; 1990 Aug; 22(4):1686-8. PubMed ID: 2389433
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate.
    Hasan RI, Sriwatanawongsa V, Wallwork J, White DJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):421-2. PubMed ID: 8438362
    [No Abstract] [Full Text] [Related]

  • 33. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA, Nakafusa Y, Yu S, Flye MW.
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allografts.
    Chen Y, Liu Y, Yuan Z, Tian L, Dallman MJ, Thompson PW, Tam PK, Lamb JR.
    Transplantation; 2007 Jun 27; 83(12):1602-10. PubMed ID: 17589344
    [Abstract] [Full Text] [Related]

  • 37. New avenues in the use of cyclosporine for transplantation. Graft and donor pretreatment.
    Cederna J, Toledo-Pereyra LH, Gof S, Rios A, MacKenzie GH, Gordon DA.
    Immunol Commun; 1984 Jun 27; 13(6):523-38. PubMed ID: 6398274
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
    Wang H, Hosiawa KA, Min W, Yang J, Zhang X, Garcia B, Ichim TE, Zhou D, Lian D, Kelvin DJ, Zhong R.
    J Immunol; 2003 Oct 01; 171(7):3823-36. PubMed ID: 14500684
    [Abstract] [Full Text] [Related]

  • 40. Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection.
    Murphy B, Kim KS, Buelow R, Sayegh MH, Hancock WW.
    Transplantation; 1997 Jul 15; 64(1):14-9. PubMed ID: 9233694
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.